This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Europe's premier partnering event
November 4–6, 2024 | Stockholm, SwedenNovember 12–13, 2024 | Digital Partnering

National University of Singapore / Protea


Protea nanotechnology was invented at the National University of Singapore in collaboration with the Singapore MIT Alliance for Research and Technology. In the 2024 QS Global rankings, MIT holds a #1 ranking and NUS a ranking of #8. The project is supported by the National Research Fund (Singapore Prime Minister’s Office) and the National Medical Research Council from the Singapore (Singapore Ministry of Health). Project Protea has, to date, raised over 5 million USD of research and commercialization funds and is currently partnered with multiple academic and commercial partners. Relevant publications for Project Protea can be found at: